Home>

Products

Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Continue shopping Get Notified

Marmoset Anti-CD20 [chunka]

Marmoset Anti-CD20 [chunka]
Product Type: New World Primate Reagents (in vitro and in vivo)
Format: Anti-CD20, 7D8, human variable region, marmoset IgG, kappa
Clone ID: [7D8]
RRID: AB_2938578
Common Names: Marmoset Anti-CD20 [chunka] | 7D8 | aCD20_7D8_hosa_Gk_caja | PR-0083 | NHP00103 | CLD41 | CAT-00185
Target: Marmoset CD20
Reactivity: Common Marmoset (Callithrix jacchus)
Applications: in vivo in vivo; depletion
Description:

Recombinant anti-CD20 engineered as a mouse-marmoset chimeric IgG-kappa.
Modifications: None
Restrictions: No
Sponsor: ORIP | R24
How to cite (Methods): Marmoset Anti-CD20 [chunka] (NHPRR Cat#PR-0083, RRID:AB_2938578)
How to cite (Acknowledgments): The Marmoset Anti-CD20 [chunka] antibody (Cat#PR-0083, RRID:AB_2938578) used in this study was provided by the Nonhuman Primate Reagent Resource (NHPRR, RRID:SCR_012986), funded by ORIP R24 OD028257.

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.

CAN'T FIND EXACTLY WHAT YOUR RESEARCH REQUIRES?

Request a Reagent:

Would you like to see an NHP-specific antibody developed through the program? Suggest a new reagent that would benefit the NHP community.

REQUEST A REAGENT

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2025